Endothelium modulates vasoconstrictor response to prostaglandin I 2 in rat mesenteric resistance arteries: Interaction between EP 1 and TP receptors

British Journal of Pharmacology

Volumn 158, Issue 7, 2009, Pages 1787-1795

  Xavier, F E ^a   Blanco Rivero, J ^b   Ferrer, M ^b   Balfagon G ^b  

^a DEPARTAMENTO DE MICOLOGIA   (Brazil)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Endothelium; Nitric oxide; Prostacyclin; Prostanoids; Resistance arteries

Indexed keywords

ACID; ACID SENSING ION CHANNEL; ADENOSINE TRIPHOSPHATE; AMILORIDE; CAPSAICIN; CAPSAZEPINE; GADOLINIUM; GENE PRODUCT; VANILLIN DERIVATIVE; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER FUNCTION; BLADDER MUCOSA; CONTROLLED STUDY; DETRUSOR MUSCLE; ELECTRIC FIELD; LAMINA PROPRIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULATION; STRETCH RECEPTOR; UROTHELIUM;

ANIMALS; BIOLOGICAL FACTORS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, THROMBOXANE; VASOCONSTRICTION;

EID: 71249119678     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00459.x     Document Type: Article

References (36)

1. Abramovitz M, Adam M, Boie Y, Carriere M, Denis D, Godbout C et al. (2000). The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 1483 : 285 293.
2. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edition (2008 revision). Br J Pharmacol 153 (Suppl. 2 S1 S209.
3. Alfranca A, Iñiguez MA, Fresno M, Redondo JM (2006). Prostanoid signal transduction and gene expression in the endothelium: Role in cardiovascular diseases. Cardiovasc Res 70 : 446 456.
4. Armstead WM (1995). Role of nitric oxide and cAMP in prostaglandin- induced pial arterial vasodilation. Am J Physiol 268 : 1436 1440.
5. 2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration. Circ Res 95 : 372 379.
6. Blanco-Rivero J, Cachofeiro V, Lahera V, Aras-Lopez R, Marquez-Rodas I, Salaices M et al. (2005). Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension 46 : 107 112.
7. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD (2001). Prostanoid receptors: Subtypes and signaling. Annu Rev Pharmacol Toxicol 41 : 661 690.
8. Bunting S, Moncada S, Vane JR (1977). Antithrombotic properties of vascular endothelium. Lancet 2 : 1075 1076.
9. + channels play a major role in mediating the vascular effects of iloprost and cicaprost. Eur J Pharmacol 356 : 215 224.
10. Corriu C, Félétou M, Edwards G, Weston AH, Vanhoutte PM (2001). Differential effects of prostacyclin and iloprost in the isolated carotid artery of the guinea-pig. Eur J Pharmacol 426 : 89 94.
11. Davis K, Ginnsburg R, Bristow M, Harrison DC (1980). Biphasic action of prostacyclin in the human coronary artery. Clin Res 28 : 165A.
12. Edwards G, Weston AH (2004). Potassium and potassium clouds in endothelium-dependent hyperpolarizations. Pharmacol Res 49 : 535 541.
13. Félétou M, Vanhoutte PM (2006). Endothelium-derived hyperpolarizing factor: Where are we now? Arterioscler Thromb Vasc Biol 26 : 1215 1225.
14. Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M (2005). Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: The Janus face of prostacyclin. Br J Pharmacol 146 : 834 845.
15. 2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase. Hypertension 50 : 525 530.
16. Jones RL, Wise H, Clark R, Whiting RL, Bley KR (2006). Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations. Br J Pharmacol 149 : 110 120.
17. Levy JV (1978). Contractile responses to prostacyclin of isolated human saphenous and rat venous tissue. Prostaglandins 16 : 93 97.
18. Levy JV (1980). Prostacyclin-induced contraction of isolated aortic strips from normal and spontaneously hypertensive rats (SHR). Prostaglandins 19 : 517 525.
19. Moncada S, Higgs EA, Vane JR (1977). Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation. Lancet 1 : 18 20.
20. Mulvany MJ, Halpern W (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41 : 19 26.
21. Narumiya S, Sugimoto Y, Ushikubi F (1999). Prostanoid receptors: Structures, properties, and functions. Physiol Rev 79 : 1193 1226.
22. Norel X (2007). Prostanoid receptors in the human vascular wall. ScientificWorldJournal 7 : 1359 1374.
23. + channels mediate relaxation by the PGI2 receptor agonist cicaprost via a cyclic AMP-independent mechanism. Cardiovasc Res 69 : 107 115.
24. Ray CJ, Marshall JM (2006). The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium. J Physiol 570 : 85 96.
25. Ray CJ, Abbas MR, Coney AM, Marshall JM (2002). Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: In vivo and in vitro studies. J Physiol 544 : 195 209.
26. Schermuly RT, Pullamsetti SS, Breitenbach SC, Weissmann N, Ghofrani HA, Grimminger F et al. (2007). Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs. Respir Res 26 : 8 4.
27. Shimokawa H, Flavahan NA, Lorenz RR, Vanhoutte PM (1988). Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig. Br J Pharmacol 95 : 1197 1203.
28. 2 antagonists. Adv Prostaglandin Thromboxane Res 6 : 493 496.
29. Tang EH, Vanhoutte PM (2008). Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol Genomics 32 : 409 418.
30. 2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc Res 78 : 130 138.
31. 2 and prostacyclin. Br J Pharmacol 154 : 1225 1235.
32. 2 mediates contraction and relaxation of vascular smooth muscle. Am J Physiol 267 : 796 803.
33. Wilson SJ, Dowling JK, Zhao L, Carnish E, Smyth EM (2007). Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: Role of receptor heterodimerization. Arterioscler Thromb Vasc Biol 27 : 290 296.
34. Wise H, Jones RL (1996). Focus on prostacyclin and its novel mimetics. Trends Pharmacol Sci 17 : 17 21.
35. Zhang XP, Hintze TH (2006). cAMP signal transduction induces eNOS activation by promoting PKB phosphorylation. Am J Physiol Heart Circ Physiol 290 : 2376 2384.
36. Zhao YJ, Wang J, Tod ML, Rubin LJ, Yuan XJ (1996). Pulmonary vasoconstrictor effects of prostacyclin in rats: Potential role of thromboxane receptors. J Appl Physiol 81 : 2595 2603.